Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer

OBJECTIVE: Oral anticoagulants (OACs), which include direct oral anticoagulants (DOACs) and warfarin, are widely used for the prevention of thromboembolic events in patients with atrial fibrillation (AF). Cancer is associated with a prothrombotic state as well as an increased bleeding risk. Few data...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasui, Taku, Shioyama, Wataru, Oboshi, Makiko, Oka, Toru, Fujita, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663538/
https://www.ncbi.nlm.nih.gov/pubmed/30799369
http://dx.doi.org/10.2169/internalmedicine.2415-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663538/
https://www.ncbi.nlm.nih.gov/pubmed/30799369
http://dx.doi.org/10.2169/internalmedicine.2415-18

Ejemplares similares